Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesKarolinska Development AB

Karolinska Development AB

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2024-06-04T03:30:01.531306Z
Market Cap
0.00M
P/E
0.02

Momentum Score

…

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
1.46
Low
2.13
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
2.04M
Revenue Per Share
0.01
Gross Profit TTM
2.30M
Debt / Equity
-
ROE
1.39%
Net Debt
-
ROCE
-3.97%
Diluted EPS TTM
0.89

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - -207.49M 302.98M 30.51M
Net income - - -207.49M 302.98M 30.51M
Selling general administrative - - 23.62M 23.47M 14.99M
Ebit -31.77M -28.61M -30.12M -38.98M -25.94M
Operating income - - -202.43M 347.94M 74.04M
Other operating expenses 6.80M 6.80M 6.80M 17.47M 13.30M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Interest income - - 5.06M 30.28M 42.78M
Total revenue - - 2.65M 3.38M 3.07M
Net income applicable to common shares -88.12M 170.82M -207.49M 302.98M 30.51M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - 890.08M 1166.70M 794.38M
Other current assets - 2.17M 40.46M 34.37M 53.06M
Total liab - - 89.82M 158.97M 498.38M
Total stockholder equity - - 800.27M 1007.73M 296.01M
Other current liab 1.04M 4.22M 7.45M 50.73M 0.87M
Common stock 2.70M 1.76M 1.76M 1.76M 0.64M
Retained earnings -1497.17M -1409.04M -1579.86M -1372.40M -1675.39M
Other liab - - - - 11.42M
Other assets 59.54M 61.80M - 1.77M 32.07M
Cash - - 75.87M 52.13M 15.84M
Total current liabilities 10.21M 138.19M 89.82M 158.97M 486.95M
Short term debt - - 75.86M 70.00M 50.00M
Other stockholder equity - 969.31M - 1005.93M -
Property plant equipment 0.69M 0.69M 0.69M 0.70M -
Total current assets 207.42M 96.62M 119.07M 116.63M 143.39M
Net tangible assets 1241.44M 971.09M 800.27M 1007.73M 296.01M
Short term investments - - 41.18M 62.62M 123.01M
Net receivables 17.31M 1.73M 2.30M 29.74M 4.35M
Accounts payable 0.44M 1.67M 0.62M 11.48M 1.37M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -119.17M -46.34M 62.70M 45.63M -25.28M
Change to liabilities 0.00M 0.00M 0.00M 0.00M 0.00M
Total cashflows from investing activities -113.81M -49.46M 57.61M 57.24M -16.62M
Net borrowings -0.71M -0.71M -0.67M -0.68M -0.68M
Total cash from financing activities 235.02M -0.71M -0.67M -14.23M -14.23M
Change to operating activities -1.66M 46.08M -33.71M 32.78M 46.51M
Net income -88.12M 170.82M -207.49M 302.98M 30.51M
Change in cash 88.68M -33.47M 23.74M 36.29M -3.46M
Total cash from operating activities -32.53M 16.70M -33.20M -6.72M 13.15M
Depreciation 0.69M 0.69M 0.69M 0.70M 0.70M
Other cashflows from investing activities 5.36M -3.12M -5.09M 11.62M 8.66M
Change to account receivables 0.42M -1.46M 29.99M -0.21M -4.37M
Other cashflows from financing activities -19.18M -19.18M -19.18M -13.54M -13.54M
Change to netincome 56.14M -199.43M 177.32M -342.97M -59.49M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital - - -3.72M 30.80M 41.80M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Tomtebodavägen 23 A, Solna, Sweden, 17165

46 8 52 48 60 70

https://www.karolinskadevelopment.com

8

Name Title Year Born
Dr. Viktor Drvota M.D., Ph.D. Chief Exec. Officer 1965
Mr. Hans Christopher HC Toll Chief Financial Officer 1968
Mr. Per Aniansson Investment Director 1966
Ms. Eva Montgomerie Head of Accounting 1958
Dr. John Öhd M.D., Ph.D. Chief Scientific Officer & Venture Partner 1971
Mr. Johan Dighed Chief Legal Officer & Deputy CEO 1973
Mr. Yan Cheng Pres Asia 1985
Ms. Linda Spahiu Investment Mang. 1985

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…